Holen Sie sich die Stockscreener-App
5.35
8.39%
-0.49
Vorhandelsmarkt:
5.40
0.05
+0.93%
Schlusskurs vom Vortag:
$5.84
Offen:
$5.85
24-Stunden-Volumen:
6.95M
Relative Volume:
1.15
Marktkapitalisierung:
$1.15B
Einnahmen:
$2.59M
Nettoeinkommen (Verlust:
$-137.89M
KGV:
-6.6049
EPS:
-0.81
Netto-Cashflow:
$-69.76M
1W Leistung:
-13.99%
1M Leistung:
+2.29%
6M Leistung:
+256.67%
1J Leistung:
+395.37%
1-Tages-Spanne:
$5.28
$5.86
1-Wochen-Bereich:
$5.28
$6.16
52-Wochen-Spanne:
$1.05
$6.75
Atai Life Sciences N V Stock (ATAI) Company Profile
Firmenname
Atai Life Sciences N V
Sektor
Branche
Telefon
49 89 2153 9035
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Vergleichen Sie ATAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
5.35 | 1.56B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten
United States Psychedelic Drugs Market 2025: Industry - openPR.com
Why Atai Life Sciences N.V. (9VC) stock appears on watchlistsPortfolio Update Summary & Long-Term Safe Investment Plans - newser.com
Is Atai Life Sciences N.V. (9VC) stock trading at attractive multiplesMarket Trend Review & Reliable Entry Point Alerts - newser.com
Is Atai Life Sciences N.V. stock poised for growthJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - newser.com
Is Atai Life Sciences N.V. (9VC) stock nearing a technical breakout - newser.com
Is Atai Life Sciences NV a good long term investmentSmall Cap Stock Opportunities & High Yield Trading Signals - earlytimes.in
Is Atai Life Sciences N.V. stock a defensive play in 2025Analyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Published on: 2025-11-03 03:02:35 - newser.com
Building trade automation scripts for Atai Life Sciences N.V.2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
Chart based analysis of Atai Life Sciences N.V. trendsQuarterly Market Review & Technical Confirmation Alerts - newser.com
Will Atai Life Sciences N.V. (9VC) stock test record highs in 2025Market Activity Summary & Free High Return Stock Watch Alerts - newser.com
Will Atai Life Sciences N.V. (9VC) stock outperform energy sector in 2025Portfolio Growth Summary & Long-Term Growth Stock Strategies - newser.com
Will Atai Life Sciences N.V. (9VC) stock justify high valuation - newser.com
Combining machine learning predictions for Atai Life Sciences N.V.Weekly Stock Analysis & Short-Term High Return Ideas - newser.com
Why analysts recommend Atai Life Sciences N.V. (9VC) stockEarnings Risk Summary & Safe Entry Zone Tips - newser.com
Will Atai Life Sciences N.V. stock sustain high P E ratiosJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Will Atai Life Sciences N.V. stock reach all time highs in 2025Market Trend Report & Safe Capital Growth Tips - newser.com
Ranking Atai Life Sciences N.V. among high performing stocks via tools2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Published on: 2025-11-01 04:43:33 - newser.com
Why Atai Life Sciences N.V. stock appeals to dividend seekersJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - newser.com
Understanding Atai Life Sciences N.V.’s price movement2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Can Atai Life Sciences N.V. stock resist sector downturns2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
Atai Life Sciences N.V. stock trend forecastTrade Volume Summary & Fast Moving Market Watchlists - newser.com
Published on: 2025-10-30 23:24:14 - newser.com
Atai Life Sciences N.V. (ATAI) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Can machine learning forecast Atai Life Sciences N.V. recovery2025 Market Overview & Risk Managed Trade Strategies - newser.com
Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):